856 followers
Pathogenic gain-of-function mutations in the prodomain and C-terminal domain of PCSK9 inhibit LDL binding https://t.co/zwUwt2CQhI
Pathogenic gain-of-function mutations in the prodomain and C-terminal domain of PCSK9 inhibit LDL binding https://t.co/zwUwt2CQhI
New Research: Pathogenic gain-of-function mutations in the prodomain and C-terminal domain of PCSK9 inhibit LDL binding https://t.co/F37fiBJeAl #Physiology